Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments

In 2024, pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments trade exhibited strong growth, with global flows reaching $1,584,273,022 and a three-year compound annual growth rate of +28.8% (five-year: +19.4%). The all-time peak of $4,639,723,991 was recorded in 2001; the current level is 66% below that high-water mark.

Over the 30-year observation window (1995–2024), 79% of years recorded positive growth, indicating a predominantly expanding market. Trend momentum is strengthening (+11.3% acceleration).

The supply side is concentrated (Herfindahl-Hirschman Index 0.522). The three largest exporters — Ireland ($1.1B), United States ($97.5M), and Italy ($50.0M) — collectively dominate supply flows. The leading exporter has grown at +48.6% over the last three years.

On the demand side, importer concentration is concentrated (HHI 0.557). The three largest import markets are Netherlands ($1.2B), United States ($71.7M), and Mexico ($29.6M). The largest importing market sources from 52 different supplying countries.

Estimated substitution elasticity: -2.98. Buyers have moderate flexibility to shift sourcing, but face some switching costs.

The dominant trade corridor is Ireland → Netherlands at $1.1B, representing 96.3% of the importer's total demand.

The volatility score for pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments is 29 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, strong demand tailwinds create a favourable entry environment. The concentrated supply structure suggests high barriers but also potential opportunity if dominant suppliers face disruption or capacity constraints.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.